HIGHLIGHTS
- who: August and colleagues from the University of São Paulo, Brazil have published the article: Endothelitis pro le in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target, in the Journal: (JOURNAL)
- what: As it can be easily detected in the human bloodstream and was proved to be stable, intact and reliable in critical patients (Gaudet et_al, 2017), the authors aimed to explore serum and urinary endocan profiles in AHF and CS patients, where endothelial activation and congestion seem to be plausible and specific hallmarks. In . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.